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JSC researchers study carcinogenesis, cancer prevention and treatment along with 
epidemiological (primarily retrospective and longitudinal) studies, modeling, and 
interactions with the environment such as radiation, nutritional, and endocrine changes 
related to space flight along with behaviors such as smoking.   
 
Cancer research is a major focus for human space flight due to the exposure to space 
radiation which consists of particles of varying charges and energies, and secondary 
neutrons.  The JSC laboratories collaborate with investigators from the U.S. as well as 
our European and Japanese partners. We use accelerator facilities at the Brookhaven 
National Laboratory, Loma Linda University and Los Alamos National Laboratory that 
generate high energy charged particles and neutrons to simulate cosmic radiation and 
solar particle events. The research using cultured cells and animals concentrates on 
damage and repair from the level of DNA to organ tissues, due to exposure to simulated 
space radiation exposure, that contribute to the induction of leukemia and solid tumors in 
most major tissues such as lung, colon, liver and breast. The goal of the research is to 
develop a mathematical model that can predict cancer morbidity and mortality risks with 
sufficient accuracy for a given space mission.   
 
For cancer prevention, JSC researchers have been investigating carbon nanoparticles as 
potential biomedical countermeasures for space radiation exposure. A modified fullerene 
(C60) with low toxicity has been demonstrated to reduce chromosome aberrations in 
cultured human cells after exposure to high energy protons and Fe ions, making the 
nanomaterial a potential candidate to be further evaluated for mitigation of space 
radiation-induced cancer risks. 
 
JSC research has also contributed to the field of radiation therapy for cancer using high 
energy protons and carbon ions which has become increasingly popular. Sensitization of 
tumor cells to radiation treatment has been one of the research areas in cancer research. 
Preliminary studies conducted at JSC have demonstrated that chemicals targeting 
autophagy and other DNA repair pathways may have a radiosensitizing effect.  
 
NASA JSC developed the “NASA Bioreactor” that has led to high fidelity Earth-based 
medical research. This invention  is  used extensively at JSC and as well as laboratories 
around the world for research in cancer, regenerative medicine, artificial organs, diabetes, 
AIDS, vaccine production, and infectious disease, among others.  It enabled enhanced 
research in academia, medical centers, industry, and government.  Tissue produced in the 
“NASA Bioreactor” is of exceptionally high quality and function, an advantage over 
conventional tissue culture methodology, for a broad range of medical applications.  
Tissue types grown include normal and transformed versions of skin, muscle, bone, 
cartilage, heart, pancreas, liver, prostate, and numerous others. The NASA Bioreactor 
enables the ability to expand tissue such as cartilage for both potential transplantation as 
well as characterization of abnormal conditions such as osteoarthritis, a condition that 
affects more than 26 million Americans. In the field of cancer research, this methodology 
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enabled the creation of 3-dimensional high fidelity tumor models of colon, ovarian, 
breast, neuronal, prostate, and others.  The higher in-vitro fidelity of tumors achieved in 
the NASA bioreactor enables better agreement with the observed in-vivo physiology 
enabling new understanding of factors controlling cell growth, differentiation, tumor-
stromal inductive interactions, and genetic expression control mechanisms.  These are 
crucial methods for the evaluation of therapeutic treatments and causative agents of 
disease.   
 
Collaborators at Emory University, utilizing enhanced in-vitro 3-dimensional tissue 
culture in the NASA Bioreactor, demonstrated improved tissue formation composed of 
both normal prostate stroma connective matrix and prostate epithelial cancer cells.  The 
improved function of this in-vitro model of prostate cancer demonstrated the 
pathophysiology of the prostate epithelium under control by host endocrine factors.  
Prostate tumors grown in the NASA Bioreactor, which emulates microgravity even on 
Earth, allowed accurate associations of the required cells into a 3-dimensional tissue and 
elicited unique Prostate Specific Antigen (PSA) secretion responses not obtained by 
conventional methods.  The NASA Bioreactor enables important tumor-stromal 
interactions, for both normal and transformed tissue growth, in a manner not possible by 
conventional culture methods.  The “NASA Bioreactor” is planned to be a core facility in 
the orbiting ISS National Laboratory and primarily managed at JSC for advanced tissue 
culture and tissue engineering research.  
 
JSC biomedical research includes all the areas related to human space flight.  These 
investigators focus on individual tissues and systems as well as the interactions between 
various disciplines.  Our biomedical research includes cardiovascular, cognition and 
behavior, exercise physiology, immunology and endocrinology, muscle physiology, 
nutrition, microbiology, pharmacology, and toxicology. NASA biomedical program has 
been central to innovative developments and use of technologies from the first bone mass 
scans to alternative uses of ultrasound for understanding changes for vision research. 
Although the primary focus is the development of countermeasures, our scientists have 
collaborations on mechanistic and tissue culture studies with external investigators from 
many universities, other national laboratories, as well as industry.  
 
 
 
 
